Vanguard Group’s enVVeno Medical NVNO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.79M | Buy |
698,339
+97,433
| +16% | +$389K | ﹤0.01% | 3412 |
|
|
2025
Q1 | $1.58M | Buy |
600,906
+11,765
| +2% | +$30.9K | ﹤0.01% | 3568 |
|
|
2024
Q4 | $1.78M | Hold |
589,141
| – | – | ﹤0.01% | 3600 |
|
|
2024
Q3 | $1.98M | Hold |
589,141
| – | – | ﹤0.01% | 3562 |
|
|
2024
Q2 | $3.09M | Buy |
589,141
+15,186
| +3% | +$79.7K | ﹤0.01% | 3424 |
|
|
2024
Q1 | $3.12M | Buy |
573,955
+237,550
| +71% | +$1.29M | ﹤0.01% | 3451 |
|
|
2023
Q4 | $1.73M | Buy |
336,405
+608
| +0.2% | +$3.13K | ﹤0.01% | 3653 |
|
|
2023
Q3 | $1.81M | Hold |
335,797
| – | – | ﹤0.01% | 3623 |
|
|
2023
Q2 | $1.03M | Hold |
335,797
| – | – | ﹤0.01% | 3888 |
|
|
2023
Q1 | $1.57M | Hold |
335,797
| – | – | ﹤0.01% | 3765 |
|
|
2022
Q4 | $1.71M | Buy |
335,797
+166
| +0% | +$847 | ﹤0.01% | 3719 |
|
|
2022
Q3 | $2.11M | Hold |
335,631
| – | – | ﹤0.01% | 3716 |
|
|
2022
Q2 | $1.27M | Buy |
335,631
+56,844
| +20% | +$215K | ﹤0.01% | 4007 |
|
|
2022
Q1 | $1.78M | Hold |
278,787
| – | – | ﹤0.01% | 4003 |
|
|
2021
Q4 | $1.84M | Buy |
278,787
+8,397
| +3% | +$55.3K | ﹤0.01% | 4076 |
|
|
2021
Q3 | $2.81M | Buy |
270,390
+11,710
| +5% | +$122K | ﹤0.01% | 3942 |
|
|
2021
Q2 | $1.78M | Buy |
258,680
+214,355
| +484% | +$1.47M | ﹤0.01% | 3997 |
|
|
2021
Q1 | $295K | Buy |
44,325
+26,755
| +152% | +$178K | ﹤0.01% | 4211 |
|
|
2020
Q4 | $152K | Buy |
+17,570
| New | +$152K | ﹤0.01% | 4111 |
|
|
2019
Q4 | – | Sell |
-60,365
| Closed | -$52K | – | 4133 |
|
|
2019
Q3 | $52K | Sell |
60,365
-87,423
| -59% | -$75.3K | ﹤0.01% | 4082 |
|
|
2019
Q2 | $154K | Buy |
147,788
+2,590
| +2% | +$2.7K | ﹤0.01% | 4008 |
|
|
2019
Q1 | $227K | Buy |
145,198
+1,800
| +1% | +$2.81K | ﹤0.01% | 3898 |
|
|
2018
Q4 | $202K | Buy |
143,398
+90,678
| +172% | +$128K | ﹤0.01% | 3900 |
|
|
2018
Q3 | $141K | Buy |
+52,720
| New | +$141K | ﹤0.01% | 4045 |
|